Jiangsu Yahong Meditech News

Jiangsu Yahong Pharmaceutical Technology Co., Ltd. voluntarily disclosed the announcement on the release of data related to the APL-1702 international multi-center phase III clinical trial at the 2024 International Papillomavirus Conference

Nov 12 11:00 ET

Yahong Pharmaceutical: Jiangsu Yahong Pharmaceutical Technology Co., Ltd. voluntarily disclosed the announcement that APL-1706 was approved for marketing by the State Drug Administration

Nov 5 11:00 ET

Jiangsu Yahong Pharmaceutical Technology Co., Ltd. voluntarily disclosed the announcement that APL-1706 was approved for marketing by the State Drug Administration

Nov 5 11:00 ET

Jiangsu Yahong Pharmaceutical Technology Co., Ltd. Investor Relations Activity Record Form (November 5, 2024)

Nov 5 03:59 ET

Yahong Pharmaceutical: Announcement of Jiangsu Yahong Pharmaceutical Technology Co., Ltd. on the progress of repurchasing the company\'s shares through centralized bidding

Nov 4 11:00 ET

Announcement of Jiangsu Yahong Pharmaceutical Technology Co., Ltd. on the progress of repurchasing the company\'s shares through centralized bidding transactions

Nov 4 11:00 ET

Jiangsu Yahong Pharmaceutical Technology Co., Ltd. Investor Relations Activity Record Form (October 30, 2024)

Oct 30 23:35 ET

Jiangsu Yahong Pharmaceutical Technology Co., Ltd. Report for the Third Quarter of 2024

Oct 29 12:00 ET

Announcement of Jiangsu Yahong Pharmaceutical Technology Co., Ltd. on completing the industrial and commercial registration of the change in the company\'s business scope and issuing a business license

Oct 29 12:00 ET

Announcement of Jiangsu Yahong Pharmaceutical Technology Co., Ltd. on holding a performance briefing for the third quarter of 2024

Oct 29 12:00 ET

Jiangsu Yahong Pharmaceutical Technology Co., Ltd. voluntarily disclosed the announcement that the APL-2302 clinical trial application was approved by the FDA

Oct 24 12:00 ET

Jiangsu Yahong Pharmaceutical Technology Co., Ltd. Investor Relations Activity Record Form (October 22, 2024)

Oct 24 05:52 ET

Announcement of Jiangsu Yahong Pharmaceutical Technology Co., Ltd. on changing the sponsor representative for continuous supervision

Oct 21 12:00 ET

Yahong Pharmaceutical: Announcement of Jiangsu Yahong Pharmaceutical Technology Co., Ltd. on the progress of repurchasing the company\'s shares through centralized bidding

Oct 8 12:00 ET

Announcement of Jiangsu Yahong Pharmaceutical Technology Co., Ltd. on the progress of repurchasing the company\'s shares through centralized bidding transactions

Oct 8 12:00 ET

Yahong Pharmaceutical: Corrective Announcement of Jiangsu Yahong Pharmaceutical Technology Co., Ltd. on the Resolutions of the 11th Meeting of the 2nd Board of Directors

Sep 29 12:00 ET

Correction Notice of Jiangsu Yahong Pharmaceutical Technology Co., Ltd. on Resolutions of the 11th Meeting of the Second Board of Directors

Sep 29 12:00 ET

Independent Financial Advisory Report of Shanghai Rongzheng Enterprise Consulting Service (Group) Co., Ltd. on matters relating to the granting of the 2024 Restricted Stock Incentive Plan by Jiangsu Yahong Pharmaceutical Technology Co., Ltd.

Sep 27 12:00 ET

Legal Opinion of Beijing Jiayuan Law Firm on the Granting of the 2024 Restricted Stock Incentive Plan of Jiangsu Yahong Pharmaceutical Technology Co., Ltd.

Sep 27 12:00 ET

Announcement of Resolutions of the 11th Meeting of the Second Board of Directors of Jiangsu Yahong Pharmaceutical Technology Co., Ltd.

Sep 27 12:00 ET